Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

Historical Holders from Q3 2021 to Q1 2025

Symbol
CLYM on Nasdaq
CUSIP
28658R106
Type / Class
Equity / Common Stock, par value $0.0001 per share
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
55.7M
Holdings value
$100M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
76
Number of buys
44
Number of sells
-30
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 39.6K $48.2K -$28.3K $1.22 2
2024 Q4 55.7M $100M -$19.4M $1.80 76
2024 Q3 54.7M $278M +$14.6M $5.09 69
2024 Q2 49.9M $355M +$245M $7.11 46
2024 Q1 16.8M $46.1M +$5.26K $2.74 19
2023 Q4 16.9M $45.5M +$348K $2.70 22
2023 Q3 16.7M $44M -$6.83K $2.63 22
2023 Q2 16.7M $46.8M +$79.3K $2.80 21
2023 Q1 16.7M $48.4M +$195K $2.90 19
2022 Q4 16.6M $61M -$1.79K $3.67 20
2022 Q3 14.8M $47.8M -$981K $3.23 20
2022 Q2 15.1M $45.7M -$21.6M $3.02 21
2022 Q1 17.5M $147M +$663K $8.39 40
2021 Q4 17.4M $182M +$168K $10.46 33
2021 Q3 17.3M $311M +$311M $17.98 32